cdk4 Deficiency Inhibits Skin Tumor Development but Does Not Affect Normal Keratinocyte Proliferation
- 31 August 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (2), 405-411
- https://doi.org/10.1016/s0002-9440(10)64196-x
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Transgenic Expression of Cyclin-Dependent Kinase 4 Results in Epidermal Hyperplasia, Hypertrophy, and Severe Dermal FibrosisThe American Journal of Pathology, 2001
- Crystallographic Approach to Identification of Cyclin-dependent Kinase 4 (CDK4)-specific Inhibitors by Using CDK4 Mimic CDK2 ProteinJournal of Biological Chemistry, 2001
- Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activationOncogene, 2000
- Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocationsOncogene, 1999
- ras activity and cyclin D1 expression: An essential mechanism of mouse skin tumor developmentMolecular Carcinogenesis, 1999
- Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Human Molecular Genetics, 1998
- Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cellsOncogene, 1997
- Physical Interaction of Mammalian CDC37 with CDK4Published by Elsevier ,1996
- D-type cyclinsTrends in Biochemical Sciences, 1995
- An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissueNature, 1986